全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量
30

相关文章

更多...
-  2019 

Severe rebound after cessation of fingolimod treated with ocrelizumab with coincidental transient aggravation: report of two cases

DOI: 10.1177/1756286419846818

Keywords: disease-modifying therapy, fingolimod, multiple sclerosis, ocrelizumab, rebound

Full-Text   Cite this paper   Add to My Lib

Abstract:

Fingolimod (FTY), an oral treatment for patients with relapsing-remitting multiple sclerosis (RRMS), has been associated with a significant rebound of disease activity after cessation of therapy

Full-Text

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133